Emergent
Highly Engaged Employees
Highly Engaged EmployeesBlood & Organ Banks · Maryland, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
400 Professional Dr Ste 400, Gaithersbur...Phone Number
(240) 631-3200Website
www.emergentbiosolutions.comRevenue
$676.8 MillionStock Symbol
EBSIndustry
ZI Rank: 21
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
17
14
21
24
18
21
About Emergent
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; RRead more
Emergent Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Emergent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Emergent had a recent Job posting/layoffs
Product Launch: Get notified when Emergent launches new products
Congratulate Masked Content for being promoted to Masked Content at Emergent
Earning: See what the market has to say on Emergent recently announced quarterly report
Check out if Emergent is spiking on competitors!
Funding: Get notified immidiatlly once Emergent has new funding data
Website visits: Recent activity has been detected on your website
Emergent, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Emergent has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Emergent
Compare insights from companies similar to Emergent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Emergent is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Emergent is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Emergent.
Emergent financials insights
Gather financial insights about Emergent, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Stock Offering
$62.5M
Emergent Tech Stack
A closer look at the technologies used by Emergent
Most Recent Scoops
Open Position
Hiring Plans
Emergent has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Emergent has more open roles in Legal than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Hiring Plans
Hiring Plans
Emergent News & Media
Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)
Emergent BioSolutions cut FY2026 revenue guidance to $645-$675 million after reaffirming a $720-$760 million outlook three months earlier. Levi & Korsinsky is investigating potential securities law violations. NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Emergent BioSolutions (NYSE: EBS)...Emergent Biosolutions Q2 Earnings Call Highlights
Emergent Biosolutions (NYSE:EBS) reported second-quarter 2026 revenue and adjusted EBITDA above its prior guidance and analyst consensus, driven by accelerated medical countermeasure deliveries to U.S. government customers. The company also lowered its full-year outlook as increased competition andEmergent BioSolutions Inc. (EBS) Q2 2026 Earnings Call Transcript
Emergent BioSolutions Inc. (EBS) Q2 2026 Earnings Call August 5, 2026 5:00 PM EDTCompany ParticipantsFrank Vargo - VP & TreasurerJoseph Papa - CEO,...Emergent BioSolutions to lay off 34 at Gaithersburg headquarters - The Baltimore Banner
The company, the manufacturer of Narcan, estimated that its restructuring will save close to $40 million per year.
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Emergent
Sign Up For FreeTo access detailed company insights
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Viv... Read More
